These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 25391375)

  • 1. TP53 engagement with the genome occurs in distinct local chromatin environments via pioneer factor activity.
    Sammons MA; Zhu J; Drake AM; Berger SL
    Genome Res; 2015 Feb; 25(2):179-88. PubMed ID: 25391375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of p53-dependent transcription and enhancer activity by the p53 family member p63.
    Karsli Uzunbas G; Ahmed F; Sammons MA
    J Biol Chem; 2019 Jul; 294(27):10720-10736. PubMed ID: 31113863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of chromatin dynamics in immune cell development.
    Winter DR; Amit I
    Immunol Rev; 2014 Sep; 261(1):9-22. PubMed ID: 25123274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pioneer factor activity of c-Myb involves recruitment of p300 and induction of histone acetylation followed by acetylation-induced chromatin dissociation.
    Fuglerud BM; Ledsaak M; Rogne M; Eskeland R; Gabrielsen OS
    Epigenetics Chromatin; 2018 Jun; 11(1):35. PubMed ID: 29954426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex enhancer-reporter assays uncover unsophisticated TP53 enhancer logic.
    Verfaillie A; Svetlichnyy D; Imrichova H; Davie K; Fiers M; Kalender Atak Z; Hulselmans G; Christiaens V; Aerts S
    Genome Res; 2016 Jul; 26(7):882-95. PubMed ID: 27197205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modifications, chromatin distribution and TP53 transcription in a model of breast cancer progression.
    Santos GC; da Silva AP; Feldman L; Ventura GM; Vassetzky Y; de Moura Gallo CV
    J Cell Biochem; 2015 Apr; 116(4):533-41. PubMed ID: 25358520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global analysis of histone modifications and long-range chromatin interactions revealed the differential cistrome changes and novel transcriptional players in human dilated cardiomyopathy.
    Liu CF; Abnousi A; Bazeley P; Ni Y; Morley M; Moravec CS; Hu M; Tang WHW
    J Mol Cell Cardiol; 2020 Aug; 145():30-42. PubMed ID: 32533974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.
    Heintzman ND; Stuart RK; Hon G; Fu Y; Ching CW; Hawkins RD; Barrera LO; Van Calcar S; Qu C; Ching KA; Wang W; Weng Z; Green RD; Crawford GE; Ren B
    Nat Genet; 2007 Mar; 39(3):311-8. PubMed ID: 17277777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 binding sites in normal and cancer cells are characterized by distinct chromatin context.
    Bao F; LoVerso PR; Fisk JN; Zhurkin VB; Cui F
    Cell Cycle; 2017; 16(21):2073-2085. PubMed ID: 28820292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte enhancers are highly altered in systemic lupus erythematosus.
    Shi L; Zhang Z; Song L; Leung YT; Petri MA; Sullivan KE
    Epigenomics; 2015; 7(6):921-35. PubMed ID: 26442457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ChromaSig: a probabilistic approach to finding common chromatin signatures in the human genome.
    Hon G; Ren B; Wang W
    PLoS Comput Biol; 2008 Oct; 4(10):e1000201. PubMed ID: 18927605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 regulates enhancer accessibility and activity in response to DNA damage.
    Younger ST; Rinn JL
    Nucleic Acids Res; 2017 Sep; 45(17):9889-9900. PubMed ID: 28973438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of chromatin and transcriptional co-regulators in mediating p63-genome interactions in keratinocytes.
    Sethi I; Sinha S; Buck MJ
    BMC Genomics; 2014 Nov; 15(1):1042. PubMed ID: 25433490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor binding dynamics during human ES cell differentiation.
    Tsankov AM; Gu H; Akopian V; Ziller MJ; Donaghey J; Amit I; Gnirke A; Meissner A
    Nature; 2015 Feb; 518(7539):344-9. PubMed ID: 25693565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dynamic H3K27ac signature identifies VEGFA-stimulated endothelial enhancers and requires EP300 activity.
    Zhang B; Day DS; Ho JW; Song L; Cao J; Christodoulou D; Seidman JG; Crawford GE; Park PJ; Pu WT
    Genome Res; 2013 Jun; 23(6):917-27. PubMed ID: 23547170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide analysis of chromatin states reveals distinct mechanisms of sex-dependent gene regulation in male and female mouse liver.
    Sugathan A; Waxman DJ
    Mol Cell Biol; 2013 Sep; 33(18):3594-610. PubMed ID: 23836885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-genome cartography of p53 response elements ranked on transactivation potential.
    Tebaldi T; Zaccara S; Alessandrini F; Bisio A; Ciribilli Y; Inga A
    BMC Genomics; 2015 Jun; 16(1):464. PubMed ID: 26081755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc-binding-site recognition in the human genome is determined by chromatin context.
    Guccione E; Martinato F; Finocchiaro G; Luzi L; Tizzoni L; Dall' Olio V; Zardo G; Nervi C; Bernard L; Amati B
    Nat Cell Biol; 2006 Jul; 8(7):764-70. PubMed ID: 16767079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide search for Zelda-like chromatin signatures identifies GAF as a pioneer factor in early fly development.
    Moshe A; Kaplan T
    Epigenetics Chromatin; 2017 Jul; 10(1):33. PubMed ID: 28676122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
    Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
    Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.